Music Album Release / FDA Phase / Patent Issuance / /
Facility
F. Port / University of California San Diego / University of California / /
IndustryTerm
target cleavage site / gRNA cut site / bioRxiv web server / insitutionally-approved barrier containment protocol / model systems / target cut site / gRNA-directed cut site / positive applications / genomic insertion site / non-insertional amplification products / /
MusicAlbum
MCR / /
Organization
National Institute of Health / G. M. Church / UCSD Institutional Biosafety Committee / G. Church / University of California / San Diego / /
Person
Michael Marshall / Ethan Bier / Sarah Sandell / / /
Position
*Corresponding author / /
Product
R461 / /
ProvinceOrState
California / /
Technology
gene therapy / MCR technology / insitutionally-approved barrier containment protocol / web server / recombinant DNA technology / /
Reports target sequence (y1) (5) in the Xlinked yellow (y) locus as the gRNA target and a vasa-Cas9 transgene as a source of Cas9 (Fig. 2C) since it is expressed in both germline and somatic cells